A Peek at ANI Pharmaceuticals's Future Earnings

ANI Pharmaceuticals (NASDAQ:ANIP) is preparing to release its quarterly earnings on Friday, 2024-11-08. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect ANI Pharmaceuticals to report an earnings per share (EPS) of $1.07.

Anticipation surrounds ANI Pharmaceuticals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Earnings History Snapshot

Last quarter the company beat EPS by $0.08, which was followed by a 9.92% drop in the share price the next day.

Here's a look at ANI Pharmaceuticals's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

0.94

0.99

0.85

0.84

EPS Actual

1.02

1.21

1

1.27

Price Change %

-10.0%

3.0%

-1.0%

-4.0%

ANI Pharmaceuticals Share Price Analysis

Shares of ANI Pharmaceuticals were trading at $58.4 as of November 06. Over the last 52-week period, shares are up 12.64%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analyst Observations about ANI Pharmaceuticals

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on ANI Pharmaceuticals.

Analysts have given ANI Pharmaceuticals a total of 5 ratings, with the consensus rating being Neutral. The average one-year price target is $73.4, indicating a potential 25.68% upside.

Comparing ...